2018
DOI: 10.1159/000486680
|View full text |Cite
|
Sign up to set email alerts
|

First-in-Class Combination Therapy of a Copper(II) Metallo-Phosphorus Dendrimer with Cytotoxic Agents

Abstract: The metallo-phosphorus dendrimer 1G3-Cu (generation 3 dendrimer bearing 48 conjugated copper(II) on its surface) has antiproliferative activity related to its capacity to activate Bax translocation. In the present study, we evaluate the activity of an association of 1G3-Cu with 5 cytotoxic agents used in chemotherapy having different modes of action. Data show no additive effect with camptothecin and cisplatin, additivity with paclitaxel and MG132, and synergy with doxorubicin. Results suggest that the multiva… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
12
0

Year Published

2019
2019
2021
2021

Publication Types

Select...
8

Relationship

5
3

Authors

Journals

citations
Cited by 12 publications
(12 citation statements)
references
References 20 publications
(28 reference statements)
0
12
0
Order By: Relevance
“…Because of many interesting properties, phosphorus dendrimers are of great interest for drug delivery applications, anti-prion, imaging [27], anti-cancer [28,29,30], and anti-inflammatory agents [31,32,33]. Moreover, polyanionic and polycationic phosphorus dendrimers have been proposed as carriers for photosensitizers in photodynamic therapy [34].…”
Section: Introductionmentioning
confidence: 99%
“…Because of many interesting properties, phosphorus dendrimers are of great interest for drug delivery applications, anti-prion, imaging [27], anti-cancer [28,29,30], and anti-inflammatory agents [31,32,33]. Moreover, polyanionic and polycationic phosphorus dendrimers have been proposed as carriers for photosensitizers in photodynamic therapy [34].…”
Section: Introductionmentioning
confidence: 99%
“…The anti-proliferative activity of To overcome cross-therapy drug resistance in cancers, the strategy of a combination of drugs using different modes of action was used [40]. The anti-proliferative activity of 1G3-Cu in a cocktail of several canonical cytotoxic drugs used in chemotherapy, such as camptothecin (topoisomerase I inhibitor), cisplatin (DNA cross-linker/intercalator), taxol (microtubule stabilizer), MG-132 (proteasome inhibitor) and doxorubicin (DNA intercalator/topoisomerase II inhibitor), is an example: no additive outcome with camptothecin and cisplatin was observed, but there was an additive response with paclitaxel and MG-132 and also a very interesting synergy with doxorubicin [32].…”
Section: Neutral Phosphorus Dendrimers As Anti-cancer Agentsmentioning
confidence: 99%
“…The main therapeutic domains developed by J.-P. Majoral and A.-M. Caminade are as follows: anti-inflammatory [ 27 , 28 ], anti-tuberculosis [ 29 ], against Alzheimer’s disease [ 30 ], antiprion [ 31 ] and anti-cancer [ 32 , 33 , 34 , 35 ]. The theragnostic realm in oncology [ 36 ] has also been developed using phosphorus dendrimers and dendrons [ 37 , 38 , 39 ].…”
Section: Introductionmentioning
confidence: 99%
“…No additive effect was observed with camptothecin and cisplatin, but it was observed with paclitaxel and MG132. More interestingly, synergy was observed with doxorubicin [ 95 ].…”
Section: Phosphorus Dendrimers As Carriers Of Anticancer “Drugs”mentioning
confidence: 99%